This complex genetic program confers migratory and invasive properties to epithelial cells during cancer, therefore, linking aberrant TGFβ signaling and EMT to PDAC and TNBC aggressiveness, loss of growth inhibition, and resistance to chemo- and radiotherapy [7,8,9]. Here, TGFB1 is linked to cancer.